sroberts on PROD1PC70 with NOTICES

Federal Register / Vol. 71, No. 236 / Friday, December 8, 2006 / Notices 71175 

subcontractors who were monitored or 

should have been monitored for exposure to 

ionizing radiation associated with radioactive 

lanthanum (RaLa) operations at Technical 

Area 10 (Bayo Canyon Site), Technical Area 

35 (Ten Site), and Buildings H, Sigma, and 

U (located within Technical Area 1) for a 

number of work days aggregating at least 250 

work days during the period from September 

1, 1944, through July 18, 1963, or in 

combination with work days within the 

parameters established for one or more 

classes of employees in the SEC. 

This designation will become 

effective on December 9, 2006, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

Pursuant to 42 U.S.C. § 7384q, in a 

October 11, 2006 letter to the Secretary 

of HHS, the Advisory Board on 

Radiation and Worker Health (‘‘the 

Board’’) advised the Secretary of HHS to 

designate the class as an addition to the 

SEC. The Board further stated, 

‘‘In their evaluation, NIOSH determined 

that it was difficult to identify people who 

worked in these areas of LANL based on job 

classifications. Therefore, the Board 

recommends that determination of eligibility 

for this class take into account this difficulty 

and in the absence of work history or other 

information to the contrary, workers at the 

LANL facility during the period in question 

should be presumed to have worked in the 

areas in question.’’ 

Since determination of eligibility is 

not within the authority of HHS, the 

Board’s recommendation on this issue 

was not included in the HHS 

designation. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV. 

Dated: November 30, 2006. 

John Howard, 

Director, National Institute for Occupational, 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 06–9587 Filed 12–7–06; 8:45 am] 

BILLING CODE 4160–17–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice of a 

decision to designate a class of 

employees at the Oak Ridge Thermal 

Diffusion Plant (S–50), Oak Ridge, 

Tennessee, as an addition to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. On 

November 9, 2006, the Secretary of HHS 

designated the following class of 

employees as an addition to the SEC: 

Employees of the Department of Energy 

predecessor agencies and their contractors 

and subcontractors who were monitored or 

should have been monitored while working 

at the S–50 Oak Ridge Thermal Diffusion 

Plant working for a number of work days 

aggregating at least 250 work day during the 

period from July 9, 1944, through December 

31, 1951, or in combination with work days 

within the parameters established for one or 

more other classes of employees in the SEC. 

This designation will become 

effective on December 9, 2006, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can be submitted by e-mail to 

OCAS@CDC.GOV. 

Dated: November 30, 2006. 

John Howard, 

Director, National Institute for Occupational, 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 06–9588 Filed 12–7–06; 8:45 am] 

BILLING CODE 4160–17–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices: Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following Federal 

Committee meeting. 

Name: Advisory Committee on 

Immunization Practices (ACIP). 

Times and Dates: 8 a.m.–6 p.m., February 

21, 2007, 8 a.m.—4 p.m., February 22, 2007. 

Place: Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE., Global 

Communications Center, Building 19, Room 

232, Atlanta, Georgia 30333. 

Status: Open to the public, limited only by 

the space available. Meeting space 

accommodates approximately 330 people. 

Overflow space for real-time viewing will be 

available. 

Purpose: The Committee is charged with 

advising the Director, CDC, on the 

appropriate uses of immunizing agents. In 

addition, under 42 U.S.C. § 1396s, the 

Committee is mandated to establish and 

periodically review and, as appropriate, 

revise the list of vaccines for administration 

to vaccine-eligible children through the 

Vaccines for Children (VFC) program, along 

with schedules regarding the appropriate 

periodicity, dosage, and contraindications 

applicable to the vaccines. 

Matters to be Discussed: The agenda will 

include discussions on influenza vaccine; 

immunization safety; update on use of 

rotavirus vaccine; update on use of HPV 

vaccine; update on use of herpes zoster 

(shingles) vaccine; vaccine supply; Japanese 

encephalitis and other flavivirus vaccines 

(e.g., yellow fever vaccine); diphtheria, 

tetanus, pertussis, polio, Haemophilus B 

[Hib] combination vaccine (Pentacel); 

evidence-based recommendations; and 

agency updates. 

Agenda items are subject to change as 

priorities dictate. 

Additional Information: In order to 

expedite the security clearance process at the 

CDC Roybal Campus located on Clifton Road, 

all ACIP attendees are required to register on 

line at www.cdc.gov/nip/acip, which can be 

found at the ‘‘Upcoming Meetings’’ tab. 

Please complete all the required fields before 

submitting your registration and submit no 

later than January 18, 2007. 

Please Note: In addition to completing the 

registration form on line, as described above, 

all non-U.S. citizens are required to complete 

the ‘‘Access Request Form.’’ The completed 

access request form should be sent by e-mail 

directly to Ms. Gardner at dgardner@cdc.gov. 

Contact Person for More Information: 

Demetria Gardner, Immunization Services 

Division, National Center for Immunization 

and Respiratory Diseases, CDC, 1600 Clifton 

Road, NE, (E–05), Atlanta, Georgia 30333, 

telephone 404/639–8836, fax 404/639–6258.